Cancer Treatment Drugs Market 2021 Global Analysis, Share, Trend, Key Players, Opportunities & Forecast To 2024
Research Reports
Jan 26, 2021
Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
The classification of cancer treatment drugs includes chemotherapy, targeted therapy, immunotherapy, hormonal therapy and others, and the revenue proportion of chemotherapy in 2016 is about 51%.
Cancer treatment drugs are widely used for blood cancer, breast cancer, gastrointestinal cancer, prostate cancer, respiratory/lung cancer and other cancers. Amongst these different cancer types, blood cancer was the largest revenue generating segment in 2016, and the revenue market share is about 22%. The growth of blood cancer segment is majorly due to the high cost of the drugs used to treat blood cancer.
Europe region is the largest supplier of cancer treatment drugs, with a revenue market share nearly 47% in 2016. North America is the second largest supplier of cancer treatment drugs, enjoying revenue market share nearly 34% in 2016. Japan region is also holding the monopoly position around the world.
North America is the largest consumption place, with the consumption market share nearly 43% in 2016, and North America market size reached 46 billion . China, India and Southeast Asia are the emerging markets, and enjoy higher grow rate.
@Get Sample Report a https://www.wiseguyreports.com/sample-request/3757328-global-cancer-treatment-drugs-market-growth-2019-2024
This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Treatment Drugs market by product type, application, key manufacturers and key regions and countries.
This study considers the Cancer Treatment Drugs value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy (Biologic Therapy)
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co.
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Merck KGaA
Ipsen
AbbVie
Gilead Sciences
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Cancer Treatment Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Cancer Treatment Drugs market by identifying its various subsegments.
Focuses on the key global Cancer Treatment Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cancer Treatment Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Cancer Treatment Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
@Enquiry Before Buying https://www.wiseguyreports.com/enquiry/3757328-global-cancer-treatment-drugs-market-growth-2019-2024
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cancer Treatment Drugs Consumption 2014-2024
2.1.2 Cancer Treatment Drugs Consumption CAGR by Region
2.2 Cancer Treatment Drugs Segment by Type
2.2.1 Chemotherapy
2.2.2 Targeted Therapy
2.2.3 Immunotherapy
2.2.4 Hormonal Therapy (Biologic Therapy)
2.2.5 Others
2.3 Cancer Treatment Drugs Consumption by Type
2.3.1 Global Cancer Treatment Drugs Consumption Market Share by Type (2014-2019)
2.3.2 Global Cancer Treatment Drugs Revenue and Market Share by Type (2014-2019)
2.3.3 Global Cancer Treatment Drugs Sale Price by Type (2014-2019)
2.4 Cancer Treatment Drugs Segment by Application
2.4.1 Blood Cancer
2.4.2 Breast Cancer
2.4.3 Gastrointestinal Cancer
2.4.4 Prostate Cancer
2.4.5 Respiratory/Lung Cancer
2.4.6 Other Cancers
2.5 Cancer Treatment Drugs Consumption by Application
2.5.1 Global Cancer Treatment Drugs Consumption Market Share by Application (2014-2019)
2.5.2 Global Cancer Treatment Drugs Value and Market Share by Application (2014-2019)
2.5.3 Global Cancer Treatment Drugs Sale Price by Application (2014-2019)
3 Global Cancer Treatment Drugs by Players
3.1 Global Cancer Treatment Drugs Sales Market Share by Players
3.1.1 Global Cancer Treatment Drugs Sales by Players (2017-2019)
3.1.2 Global Cancer Treatment Drugs Sales Market Share by Players (2017-2019)
3.2 Global Cancer Treatment Drugs Revenue Market Share by Players
3.2.1 Global Cancer Treatment Drugs Revenue by Players (2017-2019)
3.2.2 Global Cancer Treatment Drugs Revenue Market Share by Players (2017-2019)
3.3 Global Cancer Treatment Drugs Sale Price by Players
3.4 Global Cancer Treatment Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Cancer Treatment Drugs Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Cancer Treatment Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Cancer Treatment Drugs by Regions
4.1 Cancer Treatment Drugs by Regions
4.1.1 Global Cancer Treatment Drugs Consumption by Regions
4.1.2 Global Cancer Treatment Drugs Value by Regions
4.2 Americas Cancer Treatment Drugs Consumption Growth
4.3 APAC Cancer Treatment Drugs Consumption Growth
4.4 Europe Cancer Treatment Drugs Consumption Growth
4.5 Middle East & Africa Cancer Treatment Drugs Consumption Growth
…………………………
13 Research Findings and Conclusion
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Tags:
, Reportedtimes, Research Newswire, English




